PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 291 of 640

Advanced search
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Sciatica: i sintomi del nervo sciatico infiammato

Humanitas Research HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US bill could subject China-to-US pharma licensing deals to national security controls

AllSciOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM Completes Pancreatic Cancer Study Dosing; Phase 3 Planned

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright

MarketBeatOriginal source
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Diabete: i sintomi e la dieta

Humanitas Research HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Canaccord cuts CervoMed stock price target on funding uncertainty

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China’s drug firms set to compete on the world stage, analysts say

South China Morning PostOriginal source
🇺🇸Industryinvestors.amneal.comTier 1 · Company source

Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Amneal Pharmaceuticals RSSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Windlas Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA chief Tukaram Mundhe makes tea for friends in a candid viral video

indiatoday.inOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Omalizumab Outperforms Oral Immunotherapy in Landmark Multifood Allergy Clinical Trial

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Heart failure drug from Tenax Therapeutics fails in pivotal study

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstronauTx exercises option on Saniona-partnered Alzheimer's candidate

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MoonLake says Phase 3 IZAR-1 trial met all clinical endpoints at Week 16

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates NRx Pharmaceuticals stock rating at buy

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright cuts Purple Biotech stock price target on preclinical progress

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Heart Failure Drug Fails Phase 3 LEVEL Trial Endpoints

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How to Tell Substance from Branding in Biotech's Support Ecosystem

Applied Clinical Trials OnlineOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Sobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune: ‘Safe Food, Safe Medicine & Safe Maharashtra Should Be Ganeshotsav Message’, Says FDA Chief Tukaram

Free Press JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe Orders FDA Inspection of Chinese Food Stalls Across Maharashtra; Here's Why

LatestLYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DCCC, NRCC offer dueling Big Pharma attacks in NJ-7

New Jersey GlobeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Reports Mixed Topline Results from Phase 3 LEVEL Trial of TNX-103 in PH-HFpEF

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbbVie to Acquire Apogee Therapeutics for $10.9 Billion; Apogee Reports Positive Phase 2 Zumilokibart Data and Q2 2026 Results

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Sobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 push

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What is the Wolverine Peptide Stack?

HealthlineOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Vaccination coverage statistics, England (COVER programme): April 2025 to March 2026

England annual data on coverage achieved by the childhood immunisation programme.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innate Pharma plans Phase 3 lacutamab trial after Sobi deal

grafa.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Business WireOriginal source
🇺🇸CROir.labcorp.comTier 3 · Secondary coverage

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

Labcorp Drug DevelopmentOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) CEO Shift: Will CARVYKTI Leadership Rebalance Risk Between Pipeline and Commercial Focus?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wockhardt swings to ₹106 crore profit in Q1 on 26% revenue growth

cnbctv18.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veraxa Biotech Holding AG SEC Filing (Aug 10, 2026)

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

The Manila TimesOriginal source
🇺🇰Researchpirbright.ac.ukTier 2 · Direct publisher

Helen Watts appointed Interim Chief Executive Officer

The Pirbright Institute (Virology)Original source
🌍discoverynews.google.comTier 2 · Trade media

Sobi adds rare lymphoma drug with $580m Innate tie-up

pharmaphorumOriginal source
🌍Industrypiindustries.comTier 1 · Company source

Pioxaniliprole: India’s First Discovered Molecule for Crop Protection

PI Industries (Pharma)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Innate Pharma (NASDAQ: IPHA) secures Sobi deal, $75M upfront and Phase 3 push

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BeOne receives exclusive rights to four cancer medicines in select Asian markets

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cyprus biotech firm sees losses widen to €3.46m

Cyprus MailOriginal source
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Cosa sono le fratture da stress?

Humanitas Research HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Windlas Biotech Ltd June-Quarter Profit 176.5 Million Rupees

TradingViewOriginal source
🌍Regulatoryravimiamet.eeTier 1 · Regulatory source

The Estonian medicinal products market in the second quarter 2026

SAM EstoniaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - HALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE

RTTNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What therapeutic validation milestones are positioning UK biotech companies for?

Kalkine MediaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

French Hospital Brings Phage Therapy Closer to Clinical Use

MedscapeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves First Orexin-Targeting Narcolepsy Type 1 Drug

MyChesCoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial

nature.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical manufacturer Cosmos partners with Schneider for modern energy systems

citizen.digitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ingredient-focused consumption expands into inner beauty products as Dong-A Pharmaceutical unveils three Skin Solution Line items to broaden consumer choice

스포츠조선Original source
🌍discoverynews.google.comTier 3 · Aggregated media

European consortium validates continuous API manufacturing platform

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Daeryook & AJU partners with Korea pharma promoters to bolster CSO legal support - CHOSUNBIZ

ChosunbizOriginal source